Proteins and Peptides

05 Sep 2007 ThromboGenics Announces Successful Completion of Technology Transfer to
04 Sep 2007 GTC obtains FDA fast track designation for Atryn(R) and permission to submit a rolling BLA
04 Sep 2007 Jerini Regains Commercialization Rights to Icatibant for the Treatment of Hereditary Angioedema in North America
04 Sep 2007 Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE
01 Sep 2007 BioDiem starts 4 new Monash studies with eye drug BDM-E
01 Sep 2007 Somatuline(R) Depot receives marketing approval in the United States
01 Sep 2007 MediGene: European Approval Procedure for the Six-Months Dosage of Cancer Drug Eligard(R) Successfully Completed
31 Aug 2007 New formulation of multiple sclerosis treatment Rebif (R) approved in European Union
31 Aug 2007 Paion's partner Forest terminates co-development on Desmoteplase
31 Aug 2007 Pharming Presents Positive Results From European Phase III Trial Of Rhucin(R)
30 Aug 2007 King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
30 Aug 2007 Orexo's treatment for incontinence/nocturia entering Phase I
29 Aug 2007 OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
29 Aug 2007 Human genome sciences completes enrollment of first Phase 3 Albuferon(R) trial ahead of schedule
29 Aug 2007 Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
29 Aug 2007 Ambrilia Completes Patient Recruitment for the Phase 3 Pivotal Clinical Trial of its Prolonged Release Formulation of Octreotide
28 Aug 2007 Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
28 Aug 2007 IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
28 Aug 2007 AKELA Pharma Inc. enrolls first patient in its Phase IIb CGRP trial
25 Aug 2007 Phylogica enters anti-microbial field
24 Aug 2007 Teijin and Chugai enter an agreement to co-develop Ipsen's anti-diabetic medicine in Japan
24 Aug 2007 ProNAi Therapeutics announces first DNAi(R) mechanism of action studies for PNT2258 oncology drug candidate
23 Aug 2007 Nuvelo re-initiates SONOMA-3 trial of Alfimeprase in patients with catheter occlusion
23 Aug 2007 Med Discovery and DRAXIMAGE establish research collaboration
22 Aug 2007 Sinobiomed Completes Evaluation of Preclinical Safety Studies on World's First Recombinant Human Kallikrein

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up